Elisabeth Bjork - 02 Jan 2026 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork
Issuer symbol
RCKT
Transactions as of
02 Jan 2026
Net transactions value
+$34,400
Form type
4
Filing time
06 Jan 2026, 16:05:11 UTC
Previous filing
27 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bjork Elisabeth Director C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Elisabeth Bjork 06 Jan 2026 0001810406

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Purchase $34,400 +10,000 +25% $3.44 50,000 02 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 30,000 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis and vest in full on June 18, 2026.